PUBLICATIONS

Mayo Clinic Proceedings

GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Cohort Study

  • Op-Ed: Vaccine race creates blind spots
  • ZUMA-19 Abstract Accepted for Presentation at ASH 2020 Annual Meeting
  • Mayo Clinic Proceedings Lenzilumab COVID-19 Case-Control Study
  • GM-CSF and Cytokine Storm in Coronavirus
  • A new role for an old cytokine: GM-CSF amplifies GVHD
  • Role of GM-CSF in acute GVHD
  • Graft-versus-host disease, but not graft-versus-leukemia immunity, is mediated by GM-CSF–licensed myeloid cells
  • Lenzilumab Study Published in ‘blood’
  • Humanigen GM-CSF Review
  • Lenzilumab at ASH 2018 - Abstract
  • Targeting EphA3 Inhibits Cancer Growth by Disrupting the Tumor Stromal Microenvironment
  • EphA3 Publication in 'Cancers'
  • Hypoxia-Controlled EphA3 Marks a Human Endometrium-Derived Multipotent Mesenchymal Stromal Cell that Supports Vascular Growth
  • Eosinophil surface receptor EMR1: a novel therapeutic target for eosinophilic disorders

CAR-T–cell neurotoxicity: hope is on the horizon

Editorial in Blood Journal

by Omar Ahmed

©2020 Humanigen, Inc.  All rights reserved